IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 1 filers reported holding IMMUNITYBIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,774,388 | -34.8% | 1,049,934 | +7.3% | 0.00% | 0.0% |
Q2 2023 | $2,720,361 | +108.9% | 978,547 | +36.7% | 0.00% | – |
Q1 2023 | $1,302,456 | -64.5% | 715,635 | -1.1% | 0.00% | -100.0% |
Q4 2022 | $3,668,241 | +3.6% | 723,519 | +1.6% | 0.00% | 0.0% |
Q3 2022 | $3,540,000 | +100.6% | 712,218 | +50.2% | 0.00% | 0.0% |
Q2 2022 | $1,765,000 | -36.2% | 474,270 | -3.8% | 0.00% | 0.0% |
Q1 2022 | $2,767,000 | -4.5% | 493,059 | +3.5% | 0.00% | 0.0% |
Q4 2021 | $2,897,000 | -35.1% | 476,387 | +4.0% | 0.00% | 0.0% |
Q3 2021 | $4,463,000 | -36.5% | 458,205 | -6.8% | 0.00% | -50.0% |
Q2 2021 | $7,024,000 | +15.0% | 491,859 | +91.2% | 0.00% | 0.0% |
Q1 2021 | $6,107,000 | – | 257,228 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALLEN HOLDING INC /NY | 687,571 | $3,857,000 | 0.50% |
ORACLE INVESTMENT MANAGEMENT INC | 400,013 | $2,244,000 | 0.44% |
HARBOURVEST PARTNERS LLC | 335,709 | $1,883,000 | 0.38% |
Winning Points Advisors, LLC | 60,126 | $339,000 | 0.26% |
MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $541,000 | 0.19% |
SHEETS SMITH WEALTH MANAGEMENT | 203,876 | $1,144,000 | 0.16% |
Delphia (USA) Inc. | 25,504 | $143,000 | 0.11% |
Clearwater Capital Advisors, LLC | 147,891 | $830,000 | 0.10% |
Corton Capital Inc. | 36,843 | $207,000 | 0.09% |
Virtus ETF Advisers LLC | 27,343 | $153,000 | 0.07% |